Anna Coghill
@coghill_anna
Cancer Epidemiologist @MoffittResearch :: Tweets #HIVOnc
ID: 1378400088763011074
https://scholar.google.com/citations?user=6n4ZHtAAAAAJ&hl=en&oi=ao 03-04-2021 17:32:55
108 Tweet
218 Takipçi
263 Takip Edilen
Great to see a powerhouse cancer center like Moffitt Cancer Center supporting a local health organization Metro Inclusive Health that provides equitable care for all, including HIV prevention, testing, and treatment and healthcare for #PLWH #CancerFreeHIV
Two great #HIVonc studies by the amazing Jessica Y. Islam, PhD, MPH!! Such a joy and honor to collaborate on these #AACR2023 posters 👏🏽🔥💪🏽
Out today- 1st paper highlighting work with UF Health Cancer Center colleagues on lung cancer screening adherence among people with #HIV in FL. We need to do better and prioritize equitable access to cancer preventive services among this aging patient pop. #LDCT pubmed.ncbi.nlm.nih.gov/37132600/
Want to learn more about all the ways #ClimateChange impacts #Cancer ? Check out our latest publication with CRANE Lab Ana Patricia Ortiz, PhD Heather D'Angelo, PhD National Cancer Institute ACS Research AACR ASCO American Society of Preventive Oncology (ASPO) MacArthur Foundation RWJF IARC American College of Surgeons ASTRO bit.ly/3pHOjne
Colossal effort by Talal El Zarif, MD Amin Nassar, MD Elio Adib & colleagues! HUNDREDS of patients from DOZENS of international centers provide further evidence that CPIs are safe/efficacious in ppl w #HIV across CD4 counts and cancer types ascopubs.org/doi/abs/10.120…
Interesting prelim work to be presented at ASCO demonstrating 50% of registered clinical trials specify living with HIV as an exclusion criteria, for unclear reasons. Gita Suneja MD MS Anna Coghill Susan Vadaparampil check it out! #HIVonc
Oncologists need to know how to harness a multidisciplinary team to care for people with #HIV and cancer Some insights on #HIVonc #ASCO23 Journal of Clinical Oncology NCI Center for Cancer Research ascopubs.org/doi/abs/10.120…
Excited to see the important results of BV-AVD in HIV+ Hodgkin lymphoma in print! 2-yr PFS 87% and OS 92% plus increases CD4/CD8 counts. Great work by Paul Rubinstein and AMC Operations sciencedirect.com/science/articl…
The rate of liver #cancer has declined among people with #HIV in the U.S., but remains elevated. Congratulations to Jen McGee-Avila, PhD, MPH on her first first author paper Cancer Epi & Genetics! academic.oup.com/jnci/advance-a… JNCI
Excited to share this research spotlight from Cancer Epi & Genetics with Jaimie Z. Shing, PhD, MPH on anal cancer risk and survival under the mentorship of Meredith Shiels dceg.cancer.gov/news-events/ne…
📣Calling all #HIVOnc clinicians, researchers, advocates 📣 I’m really proud of Jen McGee-Avila, PhD, MPH for leading this 👇🏽new paper in Journal of Clinical Oncology examining disparities in receipt of cancer treatment for people living with HIV in the US. Cancer Epi & Genetics Meredith Shiels Jessica Y. Islam, PhD, MPH
📢Our latest contribution - People with #HIV and cancer were 𝟰𝘅 more likely to have #CHIP than similar patients without HIV. The negative impact of CH in patients with cancer is exacerbated in people with HIV. More to come... Anna Coghill Gita Suneja MD MS
New study led by Cameron B. Haas, PhD, MPH identified several rare cancers, not known to be caused by a virus, for which people with a compromised immune system had a higher risk, providing strong evidence that these cancers could be caused by an infectious agent. dceg.cancer.gov/news-events/ne…